CU6 clarity pharmaceuticals ltd

CU6 - Media and Industry News, page-714

  1. 2,318 Posts.
    lightbulb Created with Sketch. 428
    I agree with you if I agree with the metrics this study is using. I'm feeling like the article has some inherent bias. My main qualm with the figures they're using is where I'm unconvinced.



    https://hotcopper.com.au/data/attachments/6709/6709512-8af2a7bc99cc9873cbce46c533e521a9.jpg
    with two lafov they've only 1.6x the expenses vs doubling of expenses for 2x safov vs 2x safov with extended hours! My opinion is that should be swapped around.

    but you're right, more throughout is much better. The problem then comes down to Capex expenditure for these institutions. 1lafov will have less throughput vs 2safov, for a fraction of the price. I feel the business metrics still stand up for cheaper units. This does discount the whole buying state of the art factor, which is a big thing for large institutions.




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$3.80
Change
-0.580(13.2%)
Mkt cap ! $1.413B
Open High Low Value Volume
$4.35 $4.35 $3.80 $36.05M 9.179M

Buyers (Bids)

No. Vol. Price($)
15 35320 $3.80
 

Sellers (Offers)

Price($) Vol. No.
$3.82 1221 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.